[EN] METHODS AND COMPOSITIONS RELATING TO SYNTHETIC BETA-1,6 GLUCOSAMINE OLIGOSACCHARIDES [FR] PROCÉDÉS ET COMPOSITIONS SE RAPPORTANT À DES BÊTA-1,6-GLUCOSAMINE OLIGOSACCHARIDES SYNTHÉTIQUES
Disclosed are methods and kits of parts useful in inhibiting biofilm formation in vivo in subjects at risk of developing biofilms. These methods include inhibiting biofilm formation where the extracellular matrix in the biofilm includes poly-β-(1→6)glucosamine structures.
[EN] METHODS FOR PROVIDING CONTINUOUS THERAPY AGAINST PNAG COMPRISING MICROBES<br/>[FR] PROCÉDÉS POUR FOURNIR UNE THÉRAPIE CONTINUE CONTRE DES MICROBES CONTENANT PNAG
申请人:ONEBIOPHARMA INC
公开号:WO2021102320A1
公开(公告)日:2021-05-27
Disclosed are antimicrobial vaccines comprising oligosaccharide β-(1→6)-glucosamine groups.
披露了包含寡糖β-(1→6)-葡萄糖胺基团的抗微生物疫苗。
[EN] LOW CONTAMINANT ANTIMICROBIAL VACCINES<br/>[FR] VACCINS ANTIMICROBIENS À FAIBLE TENEUR EN CONTAMINANTS
申请人:ONEBIOPHARMA INC
公开号:WO2021096921A1
公开(公告)日:2021-05-20
Disclosed are antimicrobial vaccines comprising oligosaccharide β-(1→6)-glucosamine groups.
披露了包含寡糖β-(1→6)-葡萄糖胺基团的抗微生物疫苗。
Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides
申请人:The Brigham and Women's Hospital, Inc.
公开号:US10034927B2
公开(公告)日:2018-07-31
The invention relates to the compositions of synthetic oligo-β-(1→6)-2-amino-2-deoxy-D-glu-copyranosides conjugated to carriers, and methods for making and use same.